Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 12, 2016 - Issue
Submit an article Journal homepage
119
Views
29
CrossRef citations to date
0
Altmetric
Original Research

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray

Tilden EtgesGW Pharmaceuticals, Cambridge, UKCorrespondence[email protected]
,
Kari KaroliaGW Pharmaceuticals, Cambridge, UK
,
Thomas GrintGW Pharmaceuticals, Cambridge, UK
,
Adam TaylorGW Pharmaceuticals, Cambridge, UK
,
Heather LauderGW Pharmaceuticals, Cambridge, UK
,
Brian DakaGW Pharmaceuticals, Cambridge, UK
&
Stephen WrightGW Pharmaceuticals, Cambridge, UK
 show all
Pages 1667-1675 | Published online: 11 Nov 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.